FR2874612A1 - Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications - Google Patents
Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applicationsInfo
- Publication number
- FR2874612A1 FR2874612A1 FR0409140A FR0409140A FR2874612A1 FR 2874612 A1 FR2874612 A1 FR 2874612A1 FR 0409140 A FR0409140 A FR 0409140A FR 0409140 A FR0409140 A FR 0409140A FR 2874612 A1 FR2874612 A1 FR 2874612A1
- Authority
- FR
- France
- Prior art keywords
- hla
- totes
- restricted hiv
- hiv
- restricted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente Invention est relative à des peptides antigéniques du virus de l'immunodéficience humaine (VIH) comprenant au moins un épitope T CD4+ qui est restreint à une molécule HLA-DP4, et à leurs applications vaccinales et diagnostiques.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0409140A FR2874612A1 (fr) | 2004-08-27 | 2004-08-27 | Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications |
PCT/FR2005/002152 WO2006027468A2 (fr) | 2004-08-27 | 2005-08-26 | Epitopes t cd4+ du vih restreints a hla-dp4 et leurs applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0409140A FR2874612A1 (fr) | 2004-08-27 | 2004-08-27 | Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2874612A1 true FR2874612A1 (fr) | 2006-03-03 |
Family
ID=34948781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0409140A Withdrawn FR2874612A1 (fr) | 2004-08-27 | 2004-08-27 | Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2874612A1 (fr) |
WO (1) | WO2006027468A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2830940B1 (fr) | 2001-10-17 | 2007-06-15 | Commissariat Energie Atomique | Procede de selection de ligands d'hla-dp4 et ses applications |
WO2007039458A2 (fr) * | 2005-09-21 | 2007-04-12 | Cytos Biotechnology Ag | Conjugues peptidiques du vih et leurs utilisations |
WO2014002089A1 (fr) * | 2012-06-27 | 2014-01-03 | Yeda Research And Development Co. Ltd. | Peptides issus de gp41 du vih pour le traitement de pathologies à médiation par les lymphocytes t |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032456A1 (fr) * | 1997-01-23 | 1998-07-30 | Epimmune, Inc. | Identification d'epitopes a restriction dr largement reactifs |
WO2001024810A1 (fr) * | 1999-10-05 | 2001-04-12 | Epimmune Inc. | Induction de reponses immunitaires cellulaires au virus de l'immunodeficience humaine de type 1 a l'aide de compositions de peptides et d'acides nucleiques |
US20040001851A1 (en) * | 2001-11-07 | 2004-01-01 | Haynes Barton F. | Polyvalent immunogen |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0330359A3 (fr) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I |
EP0339504A3 (fr) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Virus d'immunodéficience humaine (HIV) peptide env-codé capable de provoquer les anticorps inhibiteurs du HIV dans les mammifères |
US5696238A (en) * | 1991-08-20 | 1997-12-09 | Chiron Corporation | Purified GP120 composition retaining natural conformation |
DE69231705T2 (de) * | 1992-06-04 | 2001-10-18 | Univ Osaka Res Found | Gag-Env Fusion-Antigen aus HIV |
CA2528727A1 (fr) * | 2003-06-10 | 2004-12-16 | The University Of Melbourne | Compositions immuno-modulatrices, leurs utilisations et leurs procedes de production |
-
2004
- 2004-08-27 FR FR0409140A patent/FR2874612A1/fr not_active Withdrawn
-
2005
- 2005-08-26 WO PCT/FR2005/002152 patent/WO2006027468A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032456A1 (fr) * | 1997-01-23 | 1998-07-30 | Epimmune, Inc. | Identification d'epitopes a restriction dr largement reactifs |
WO2001024810A1 (fr) * | 1999-10-05 | 2001-04-12 | Epimmune Inc. | Induction de reponses immunitaires cellulaires au virus de l'immunodeficience humaine de type 1 a l'aide de compositions de peptides et d'acides nucleiques |
US20040001851A1 (en) * | 2001-11-07 | 2004-01-01 | Haynes Barton F. | Polyvalent immunogen |
Non-Patent Citations (4)
Title |
---|
NAKAMURA Y ET AL: "A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 15, no. 5, 5 April 1997 (1997-04-05), pages 489 - 496, XP004059887, ISSN: 0264-410X * |
NISHINO Y ET AL: "IN VIVO INDUCTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-SPECIFIC CYTOTOXIC T LYMPHOCYTES AND DELAYED-TYPE HYPERSENSITIVITY BY A 23-AMINO ACID PEPTIDE FROM THE HIGHLY CONSERVED REGION IN MAJOR CORE PROTEIN P24", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 12, no. 6, May 1994 (1994-05-01), pages 485 - 491, XP000882395, ISSN: 0264-410X * |
PANCRÉ V ET AL.: "Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, vol. 129, 2002, pages 429 - 437, XP002321844 * |
SONG YUB SHIN ET AL: "CHARACTERIZATION OF KI-24, A NOVEL MURINE MONOCLONAL ANTIBODY WITH SPECIFIC REACTIVITY FOR THE HUMAN IMMUNODEFICIENCY VIRUS-1 P24 PROTEIN", JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 33, no. 1, 31 January 2000 (2000-01-31), pages 92 - 95, XP009040726, ISSN: 1225-8687 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006027468A2 (fr) | 2006-03-16 |
WO2006027468A3 (fr) | 2006-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL397776A1 (pl) | Kompleks rozpuszczalny obejmujący retrowirusową glikoproteinę powierzchniową oraz kompozycja obejmująca ten kompleks | |
CY1108299T1 (el) | Πεπτιδια του ιου ανθρωπινης ανοσοανεπαρκειας (hiv), αντιγονα και συνθεσεις εμβολιου | |
DE602006011859D1 (de) | T-cd4+-epitope der latenzantigene typ i und ii des epstein-barr-virus, die bei der mehrzahl von individuen in der kaukasischen bevölkerung erkannt werden können, und anwendungen davon | |
WO2006013106A3 (fr) | Vaccin | |
WO2002020554A3 (fr) | Peptides vih, antigenes, compositions de vaccin, coffret de dosage immunologique et procede permettant la detection d'anticorps induits par vih | |
CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
DK0512112T3 (da) | Anti-CD4-antistoffer, som blokerer HIV-inducerede syncytier | |
DE69737736D1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
HUP0202502A2 (hu) | Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására | |
BR0108210A (pt) | Vacina contra o vìrus da imunodeficiência humana | |
ATE306938T1 (de) | Verwendung von cpg als adjuvans für hivimpstoff | |
ATE333500T1 (de) | Virus des porzinen reproduktiven und respiratorischen syndroms und dessen verwendung | |
PT815124E (pt) | Inibidores protease retroviral sulfonamida hidroxietilamino aminoacido heterociclocarbonilo | |
DK1765337T3 (da) | Kombination af tenofovir, ritonavir og TMC114 | |
FR2647810B1 (fr) | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus | |
NO20014841L (no) | Anti-HIV-1 vaksine som omfatter hele eller del av HIV-1 TAT proteinet | |
FR2874612A1 (fr) | Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications | |
HUP0303132A2 (hu) | Szabályozó és kiegészítő HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és HIV által indukált antitestek detektálására szolgáló eljárás | |
ATE180512T1 (de) | Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik | |
MA34215B1 (fr) | Traitement d'association comprenant un antagoniste du récepteur ccr5, un inhibiteur de la protéase du vih-1 et un accélérateur pharmacocinétique | |
CY1105629T1 (el) | Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv | |
FR2868318B1 (fr) | Antigene tat stabilise et ses applications pour la vaccination anti-vih | |
JP2007516701A5 (fr) | ||
WO2003029285A3 (fr) | Identification de nouveaux epitopes cd8 des proteines du vih-1 presentant des proprietes therapeutiques et vaccinales contre les infection par le vih | |
EP1370697A4 (fr) | Medicaments a base de peroxyredoxine pour le traitement d'infections par le vih-1, et leurs methodes d'utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20080430 |